Bliss GVS Pharma Limited — Important, 24-10-2024: Financial Result Updates

The Board of Bliss GVS Pharma approved the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2024. Mr. Nandkumar Kashinath Chodankar was appointed as the new Chairman, replacing Mr. Subramanian Ramaswamy Vaidya. The Company has paid imposed fines for regulatory non-compliance related to Mr. Chodankar's earlier appointment without shareholder approval, despite securing approval at the AGM. The Company remains committed to regulatory compliance.